Search Hotels in Sausalito

Zoetis Announces Health Canada Approval of Lenivia® (izenivetmab injection) for Alleviation of Osteoarthritis (OA) Pain in Dogs

October 15, 2025

From Zoetis Inc.

Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.

1 Profitable Stock for Long-Term Investors and 2 Facing Headwinds

October 14, 2025

Zoetis Receives Positive Opinion from CVMP for Lenivia® (izenivetmab) to Reduce Pain Associated with Osteoarthritis (OA) in Dogs

How Do Investors Really Feel About Zoetis? ↗

September 23, 2025

Via Benzinga

Analyst Expectations For Zoetis's Future ↗

September 09, 2025

Via Benzinga

October 10, 2025

From Zoetis Inc.

Zoetis (NYSE:ZTS) Signals Robust Health with Q4 2025 Dividend Declaration, Bolstering Investor Confidence in Animal Health Sector

October 09, 2025

Parsippany, N.J. – October 9, 2025 – Zoetis Inc. (NYSE:ZTS), the world's leading animal health company, today declared a quarterly dividend of $0.50 per share for the fourth quarter of 2025. This...

In a period marked by broader market retreats and economic uncertainties, the healthcare sector is emerging as a beacon of resilience, demonstrating its enduring defensive nature. As of October 9,...

Topics Economy

Healthcare Sector Shines as a Defensive Anchor Amidst Market Volatility

October 09, 2025

NEW YORK, NY – October 9, 2025 – Zoetis Inc. (NYSE:ZTS), the world's leading animal health company, today announced a quarterly dividend of $0.50 per share for the fourth quarter of 2025. This...

Topics Artificial Intelligence Economy Intellectual Property

Zoetis (NYSE:ZTS) Declares $0.50 Q4 2025 Dividend, Signaling Robust Animal Health Market

October 09, 2025

Zoetis Declares Fourth Quarter 2025 Dividend

October 09, 2025

From Zoetis Inc.

Both have increased their payouts at a terrific pace over the past decade.

2 Magnificent Dividend Stocks to Buy Now and Hold Forever ↗

October 08, 2025

These two stocks will be at the top of my shortlist of stocks to add to in October.

My 2 Favorite Stocks to Buy Right Now ↗

October 05, 2025

Could Zoetis be the next big opportunity in the pet medicine market? Tune in as our experts break down the company's strengths and weaknesses.

Zoetis: A Solid Investment in the Growing Pet Medicine Market? ↗

October 02, 2025

Zoetis Receives Conditional Approval for Dectomax®-CA1 Injectable for the Prevention and Treatment of New World Screwworm Myiasis in Cattle

September 30, 2025

From Zoetis Inc.

The global cattle feeding industry is at a critical juncture, facing mounting pressures from volatile feed costs, stringent environmental regulations, and a persistent labor crunch. In response, a wave...

Tech Revolutionizes Cattle Feeding: A Sustainable Future for Livestock Markets

September 30, 2025

The past year hasn't been kind to the stocks featured in this article. Each has tumbled to their lowest points in 12 months, leaving investors to decide whether they're witnessing fire sales or falling...

Topics Artificial Intelligence Climate Change Emissions

2 Oversold Stocks Primed to Rebound and 1 Facing Challenges

September 26, 2025

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because...

1 of Wall Street’s Favorite Stock on Our Watchlist and 2 Facing Headwinds

September 24, 2025

Zoetis to Host Webcast and Conference Call on Third Quarter 2025 Financial Results

September 23, 2025

From Zoetis Inc.

Zoetis Inc (NYSE:ZTS) Demonstrates Strong Quality Investing Traits in Caviar Cruise Screen ↗

September 23, 2025

Zoetis (ZTS) excels in quality investing with strong revenue growth, a high 48% ROIC, and solid cash flow. Its financial health meets strict Caviar Cruise screening standards for long-term value.

Via Chartmill

1 S&P 500 Stock Worth Investigating and 2 Facing Headwinds

September 15, 2025

While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural...

Zoetis Receives Positive Opinion from CVMP for Portela® (relfovetmab) to Alleviate Pain Associated with Osteoarthritis in Cats

Topics Stocks

September 12, 2025

From Zoetis Inc.

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.

1 Cash-Producing Stock to Consider Right Now and 2 That Underwhelm

September 11, 2025

Zoetis to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

August 27, 2025

From Zoetis Inc.

Over the past six months, Zoetis’s shares (currently trading at $156.80) have posted a disappointing 7% loss, well below the S&P 500’s 8.6% gain. This might have investors contemplating their next...

2 Reasons to Watch ZTS and 1 to Stay Cautious

August 25, 2025

Winners And Losers Of Q2: Zoetis (NYSE:ZTS) Vs The Rest Of The Branded Pharmaceuticals Stocks

Topics Government Stocks World Trade

August 17, 2025

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how branded pharmaceuticals stocks fared in Q2, starting with...

ZTS Q2 Deep Dive: Market Questions Librela Outlook Amid Double-Digit Growth in Core Franchises

Topics Artificial Intelligence Intellectual Property

August 13, 2025

Animal health company Zoetis (NYSE:ZTS) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 4.2% year on year to $2.46 billion. The company expects the full year’s revenue to be around...

Dip into a beaten-down market sector for deals on some proven winners.

Got $1,000? 3 Dividend Stocks to Buy and Hold Forever ↗

August 12, 2025

Zoetis Announces Pricing of $1.85 Billion of Senior Notes

August 11, 2025

From Zoetis Inc.

If You'd Invested $1,000 in Zoetis (ZTS) Stock 10 Years Ago, Here's How Much You'd Have Today ↗

August 11, 2025

The short-term picture has been less rosy than the longer-term one.

Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it more challenging to maintain high growth...

3 Large-Cap Stocks with Promising Prospects

August 11, 2025